Image

    Pharmacological Activity and Clinical Use of Polydeoxyribonucleotide

    April 2017 in “ Frontiers in Pharmacology
    Francesco Squadrito, Alessandra Bitto, Natasha Irrera … Domenica Altavilla
    Studysummary This review examines experimental and clinical evidence on PDRN, a drug derived from salmon DNA that acts via the adenosine A2A receptor and shows promise for tissue repair and treatment of diabetic foot ulcers in regenerative medicine.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on frontiersin.org →
    Discuss this study in the Community →